Pharmaceutical Industry Information Portal

HomeTagsPromomed Group

All posts by tag

Promomed Group

M. Smagin: a competent system of joint planning of drugs procurements by the government and pharmaceutical business will eliminate possible shortages

In his speech at the «360 degree Pharmaceutical Supply» conference, Maxim Smagin, General Director of Promomed Group said: The domestic health care system has...

Kira Zaslavskaya: we need joint and responsible work of all participants in the pharmaceutical market

«Vision and participation are essential to address global pharmaceutical safety challenges, including the fight against the pandemic. This means that only in conditions of...

Efficacy of Areplivir (favipiravir) in the treatment of COVID-19 discussed at the 16th Russian Congress of Internal Medicine

On the first day of the 16th Russian Congress of Internal Medicine, Promomed Group organized a satellite symposium «Always on the same side against...

The first Russian injectable drug for treatment of COVID-19 is ap-proved

The first Russian direct-acting intravenous antiviral drug Areplivir® (favipiravir) received marketing authorization certificate and its supply to hospitals in all regions will start by...

Revenue of PROMOMED DM LLC for 9 months of 2021 increased by 194.74% and amounted to RUB 13.25 bln.

PROMOMED DM LLC publishes financial statements for 9 months of 2021 compiled in accordance with Russian Accounting Standards (RAS). According to the results of 9...

Promomed Group received approval for the first drug in its portfolio for treatment of HIV infection

Ritonavir, used for the treatment of HIV infection and viral hepatitis C, received the marketing authorization certificate and became the first drug in the...
spot_img

Expert Articles

spot_img